ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

COVID and Coagulation

Theme Navigation

  • ISTH 2021 Congress
    • COVID and Coagulation
      • COVID and Coagulation, Basic Science
      • COVID and Coagulation, Clinical

Abstract Number: PB0186

A Weight-based Approach to Thromboprophylaxis Dosing for Medical Inpatients with COVID-19

R. Price1, Z. Kirkham1,2, A. Szuman1, S. Ahmed3, C. Macaulay4, K. Talks5, B. Greystoke5, K. Musgrave2,5

Abstract Number: PB0190

ACE2, ACE and Thromboinflammation in COVID-19

A. Lundström1, L. Ziegler1, S. Havervall1, A.-S. Rudberg1, F. Von Meijenfeldt2, T. Lisman2, N. Mackman3, P. Sandén1, C. Thålin1

Abstract Number: PB0299

Acute Liver Necrosis in a Sars-Cov-2 Positive Patient with Triple Positive Antiphospholipid Syndrome

V. La Mura1,2, R. Gualtierotti1,3, I. Martinelli1, B. Ferrari1, A.M. Ierardi4, N. Bitto1, G. Ghigliazza1, A. Giachi1, M. Maggioni5, M. Cugno1,3, A.L. Fracanzani3,6, G. Carrafiello4,7, F. Peyvandi1,3

Abstract Number: PB0168

Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)

L. Khider1, B. Planquette1, A. Le Berre2, S. Soudet3, G. Pernod4, R. Le Mao5, M. Besutti6, N. Gendron1, A. Yannoutsos2, D.M. Smadja1, G. Goudot1, T. Mirault1, E. Messas1, J. Emmerich2, F. Couturaud5, G. Ferretti4, M.-A. Sevestre3, N. Meneveau6, G. Chatellier1, O. Sanchez1

Abstract Number: PB0270

After the Storm; 6-month Follow up Outcomes and Management of COVID-19 Related Venous Thromboembolism

M. Ahmed1, R. Khan1, E. Xenou1, M. Fowler1, S. Sinha1, A. Lokare1, C. Kartsios1

Abstract Number: PO129

Alterations of the Coagulation Profile in Peruvians Admitted for Pneumonia due to SARS-COV2: Cross-sectional Study

R. Pichardo Rodriguez1,2, W. Peña-Oscuvilca1, L. Cordova-Cueva3, O. Ruiz-Franco2, F. Garmendia-Lorena2

Abstract Number: OC 15.2

Altered Platelet Proteome and Platelet-leukocyte Interactions in Patients with COVID-19

L. Goudswaard1, C. Williams1, F. Hamilton2, D. Arnold2, A. Davidson1, A. Poole1, I. Hers1

Abstract Number: PB0159

Altered Protein S Activity Contributes Significantly to COVID-19 Pro-thrombotic State

T. Nguyen1, D. Melancon1, M. Dean2, A. Zea3, S. Chatterjee1, J. Harman1, V. Pilli1, R. Nossaman4, J. Ochoa4, A. Ochoa2, R. Majumder1

Abstract Number: PB0300

Analysing Risk Factors for Thrombosis in Covid-19 and Cancer Patients

B. Obispo Portero1, J. Rogado1, G. Serrano1, C. Pangua1, A. Lopez1, A. Martin1, M. Perez1, M.A. Lara1

Abstract Number: PB0204

Anemia and Enhancement of Coagulation Are Associated during Severe COVID-19 Infection

T. Helin1, M. Lemponen1, T. Lahtiharju1, R. Lassila2, L. Joutsi-Korhonen1

Abstract Number: PB0280

Anti-coagulant Drugs among Moderate, Severe and Critically Ill COVID 19 Patients in the Second Referral Hospital in Surabaya

P.Z. Romadhon1, S.D. Suryantoro1, C. Windradi1, B.A. Mahdi1, E.D. Agustin1, D. Novendrianto1, K.N. Widiastuti1, M. Savitri1, P.N.A. Amrita1, M Noordiansyah1, S. YB1, A. Ashariati1

Abstract Number: PB0184

Anti-factor Xa Activity after Intermediate Dose Nadroparin for Thrombosis Prophylaxis in Critically Ill COVID-19 Patients with and without Acute Kidney Injury

R. Eck1, J. van Leur2, M. Lukens1, W. Bult1, R. Gans1, K. Meijer1, F. Keus1

Abstract Number: OC 70.2

Anti-thrombotics and Anti-hypertensives with Direct Action against SARS-CoV-2

M. Brennan1, A. Chubb1

Abstract Number: PB0262

Anticoagulant Response to Tailored Low Molecular Weight Heparin Regimens in Patients with COVID-19 Infection

A. Artoni1, V. De Zan1, M. Boscarino1, C. Novembrino1, E. Scalambrino1, S. Aliberti2, M. Panigada3, I. Martinelli1, A. Tripodi1, F. Peyvandi1,4

Abstract Number: PB0202

Anticoagulation Strategies and Risk Of Bleeding Events in Critically ill COVID-19 Patients

C. Gabara1, B. Solarat2, P. Castro1,3, S. Fernández1,3, J.R. Badia2, D. Toapanta4, S. Schulman5, J.C. Reverter6, A. Soriano7, J. Moises2, J. Aibar1

Abstract Number: PB0230

Anticoagulation with Tinzaparin in COVID-19 Patients in ICU: Are Low Anti-Xa Levels Associated with the Development of Thrombo-embolic Events?

R. Van Lancker1, S. Demeester2, K. Jochmans2, M. Mekeirele1

Abstract Number: PB0247

Apparent Different of Lupus Anticoagulant Disappearance in Novel Coronavirus 2019 Patients as a Distinct Clinical Feature

H. Kim1, M.-S. Kim2, S. Jang1

Abstract Number: PB0173

Are Mild or Moderate COVID-19 Patients at Higher Risk of VTE? A Comparison of Two Prospective European Cohorts in Emergency Departments

D. Douillet1,2, J. Riou3,4, A. Penaloza5, T. Moumneh1,2, C. Soulié6, D. Savary1,7, F. Morin1, R. Mahieu8,9, P.-M. Roy1,2

Abstract Number: PB0249

Artificial Neural Networks to Predict Covid-19 Progression of Moderate Hospitalized Patients using Early Clinical Parameters and Blood Tests

T.D. Martins1, S.D. Martins2, S.A.L. Montalvão2, G.Y. Ottaiano1, M. Al Bannoud1, L.Q. Silva2, S.C. Huber2, T.S. Diaz3, C.K. Wroclawski4, C.C. Filho4, R.M. Filho5, J.M. Annichino-Bizzacchi2

Abstract Number: PO127

Association between FGB – 455 G/A and PAI-1 – 675 5G / 4G Gene Polymorphisms and Covid-19 Severity

B. Vatseba1, N. Virstyuk1

  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »

« View all themes from the ISTH 2021 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley